FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2340601076> ?p ?o ?g. }

• W2340601076 endingPage "2009" @default.
• W2340601076 startingPage "2003" @default.
• W2340601076 abstract "Purpose Trastuzumab is a key component of adjuvant therapy for stage I to III human epidermal growth factor receptor 2 (HER2)–positive breast cancer. The rates and patterns of trastuzumab use have never been described in a population-based sample. The recent addition of HER2 information to the SEER-Medicare database offers an opportunity to examine patterns of trastuzumab use and to evaluate possible disparities in receipt of trastuzumab. Methods We examined a national cohort of Medicare beneficiaries with incident stage I to III HER2-positive breast cancer diagnosed in 2010 and 2011 (n = 1,362). We used insurance claims data to track any use of trastuzumab in the 12 months after diagnosis as well as to identify chemotherapy drugs used in partnership with trastuzumab. We used modified Poisson regression analysis to evaluate the independent effect of race on likelihood of receiving trastuzumab by controlling for clinical need, comorbidity, and community-level socioeconomic status. Results Overall, 50% of white women and 40% of black women received some trastuzumab therapy. Among women with stage III disease, 74% of whites and 56% of blacks received trastuzumab. After adjustment for tumor characteristics, poverty, and comorbidity, black women were 25% less likely to receive trastuzumab within 1 year of diagnosis than white women (risk ratio, 0.745; 95% CI, 0.60 to 0.93). Conclusion Approxemately one half of patients 65 years of age and older with stage I to III breast cancer do not receive trastuzumab-based therapy, which includes many with locally advanced disease. Significant racial disparities exist in the receipt of this highly effective therapy. Further research that identifies barriers to use and increases uptake of trastuzumab could potentially improve recurrence and survival outcomes in this population, particularly among minority women." @default.
• W2340601076 created "2016-06-24" @default.
• W2340601076 creator A5004390593 @default.
• W2340601076 creator A5037665786 @default.
• W2340601076 creator A5041418355 @default.
• W2340601076 creator A5044678886 @default.
• W2340601076 creator A5052268581 @default.
• W2340601076 date "2016-06-10" @default.
• W2340601076 modified "2023-10-16" @default.
• W2340601076 title "Disparities in Use of Human Epidermal Growth Hormone Receptor 2–Targeted Therapy for Early-Stage Breast Cancer" @default.
• W2340601076 cites W1526167931 @default.
• W2340601076 cites W1919048041 @default.
• W2340601076 cites W1977270661 @default.
• W2340601076 cites W1985213644 @default.
• W2340601076 cites W1996778928 @default.
• W2340601076 cites W2005005574 @default.
• W2340601076 cites W2014516834 @default.
• W2340601076 cites W2031096462 @default.
• W2340601076 cites W2040935952 @default.
• W2340601076 cites W2046454843 @default.
• W2340601076 cites W2060241882 @default.
• W2340601076 cites W2063624148 @default.
• W2340601076 cites W2068228843 @default.
• W2340601076 cites W2076672860 @default.
• W2340601076 cites W2084314714 @default.
• W2340601076 cites W2095633632 @default.
• W2340601076 cites W2097541112 @default.
• W2340601076 cites W2098775844 @default.
• W2340601076 cites W2108326787 @default.
• W2340601076 cites W2110560439 @default.
• W2340601076 cites W2112652525 @default.
• W2340601076 cites W2112669742 @default.
• W2340601076 cites W2113450161 @default.
• W2340601076 cites W2122293686 @default.
• W2340601076 cites W2122679888 @default.
• W2340601076 cites W2123753957 @default.
• W2340601076 cites W2146384083 @default.
• W2340601076 cites W2149908785 @default.
• W2340601076 cites W2156284376 @default.
• W2340601076 cites W2159427817 @default.
• W2340601076 cites W2163059845 @default.
• W2340601076 cites W2164669790 @default.
• W2340601076 cites W2597872842 @default.
• W2340601076 cites W4250849363 @default.
• W2340601076 cites W4292490920 @default.
• W2340601076 cites W61493659 @default.
• W2340601076 doi "https://doi.org/10.1200/jco.2015.65.8716" @default.
• W2340601076 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4966516" @default.
• W2340601076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27069085" @default.
• W2340601076 hasPublicationYear "2016" @default.
• W2340601076 type Work @default.
• W2340601076 sameAs 2340601076 @default.
• W2340601076 citedByCount "55" @default.
• W2340601076 countsByYear W23406010762016 @default.
• W2340601076 countsByYear W23406010762017 @default.
• W2340601076 countsByYear W23406010762018 @default.
• W2340601076 countsByYear W23406010762019 @default.
• W2340601076 countsByYear W23406010762020 @default.
• W2340601076 countsByYear W23406010762021 @default.
• W2340601076 countsByYear W23406010762022 @default.
• W2340601076 countsByYear W23406010762023 @default.
• W2340601076 crossrefType "journal-article" @default.
• W2340601076 hasAuthorship W2340601076A5004390593 @default.
• W2340601076 hasAuthorship W2340601076A5037665786 @default.
• W2340601076 hasAuthorship W2340601076A5041418355 @default.
• W2340601076 hasAuthorship W2340601076A5044678886 @default.
• W2340601076 hasAuthorship W2340601076A5052268581 @default.
• W2340601076 hasBestOaLocation W23406010762 @default.
• W2340601076 hasConcept C121608353 @default.
• W2340601076 hasConcept C126322002 @default.
• W2340601076 hasConcept C143998085 @default.
• W2340601076 hasConcept C146357865 @default.
• W2340601076 hasConcept C151730666 @default.
• W2340601076 hasConcept C2779786085 @default.
• W2340601076 hasConcept C2908647359 @default.
• W2340601076 hasConcept C29456083 @default.
• W2340601076 hasConcept C530470458 @default.
• W2340601076 hasConcept C71924100 @default.
• W2340601076 hasConcept C72563966 @default.
• W2340601076 hasConcept C86803240 @default.
• W2340601076 hasConcept C99454951 @default.
• W2340601076 hasConceptScore W2340601076C121608353 @default.
• W2340601076 hasConceptScore W2340601076C126322002 @default.
• W2340601076 hasConceptScore W2340601076C143998085 @default.
• W2340601076 hasConceptScore W2340601076C146357865 @default.
• W2340601076 hasConceptScore W2340601076C151730666 @default.
• W2340601076 hasConceptScore W2340601076C2779786085 @default.
• W2340601076 hasConceptScore W2340601076C2908647359 @default.
• W2340601076 hasConceptScore W2340601076C29456083 @default.
• W2340601076 hasConceptScore W2340601076C530470458 @default.
• W2340601076 hasConceptScore W2340601076C71924100 @default.
• W2340601076 hasConceptScore W2340601076C72563966 @default.
• W2340601076 hasConceptScore W2340601076C86803240 @default.
• W2340601076 hasConceptScore W2340601076C99454951 @default.
• W2340601076 hasIssue "17" @default.
• W2340601076 hasLocation W23406010761 @default.
• W2340601076 hasLocation W23406010762 @default.
• W2340601076 hasLocation W23406010763 @default.

• next